Progress of CF discoveries
It should be uplifting to all when considering the great strides there have been in the diagnosis and treatment of CF over the past quarter-century.
A new assessment to help in making treatment decisions is known as Walk-DMC. It is beneficial in making procedure choices as it predicts the probable outcome of “aggressive treatment.”
Researchers have learned the job of the CFTR genetic protein is to regulate the passage of salt and water across cell membranes. As the CFTR defect prevents this process, mucus becomes thick and sticky.